The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
Category: Drugs (Pharmaceuticals)
-
Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pill
The journal found that the studies, which had suggested that medication abortion is unsafe, included incorrect factual assumptions and misleading presentation of the data.
-
J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices
The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.
-
Medicare Recipients Can Save on Drugs in 2024
Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.
-
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
-
U.S. Makes Initial Offers in Medicare Drug Price Negotiations
The offers amount to a starting gun in the price talks between the federal government and the makers of 10 prescription drugs that have been selected for negotiations.
-
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.
-
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.
-
Six Reasons Drug Prices Are So High in the U.S.
Research shows prices in the United States are nearly double those in other well-off countries.
-
The Billionaires Spending a Fortune to Lure Scientists Away From Universities
Arena BioWorks is promising big paydays to nearly 100 researchers from Harvard, M.I.T. and other prestigious institutions.
-
Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.
With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.
-
Sidney M. Wolfe, Scourge of the Pharmaceutical Industry, Dies at 86
For over 40 years, he and his organization, the Health Research Group, held government and manufacturers to account for unsafe medication.